A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Colorectal Cancer · Relapse

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, China
Contact: Study coordinator (Qingguo Li, M.D.) · qingguoli@fudan.edu.cn · 18918298120

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nanjing, China

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Huntsville, United States · Fullerton, United States

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Colon Carcinoma · Colorectal Carcinoma · Rectal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Atlanta, United States

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Colorectal Cancer; Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Orange, United States · Hsinchu, Taiwan